Literature DB >> 15086895

Mechanism of steroid action in renal epithelial cells.

Simone de Haij1, Mohamed R Daha, Cees van Kooten.   

Abstract

Renal tubular epithelial cells (TEC) are thought to play an active role in tubulointerstitial inflammation. Various immune and non-immune factors activate TEC to produce a variety of cytokines and chemokines, contributing to attraction of inflammatory cells to the kidney. The proinflammatory transcription factor nuclear factor-kappaB (NF-kappaB) appears to be a key player in these responses and tubular expression of NF-kappaB has been demonstrated in vitro and in vivo. Although glucocorticoids are known to inhibit NF-kappaB activation at different levels, the proinflammatory capacity of TEC was not inhibited. In contrast, glucocorticoids seemed to enhance the profibrotic response of TEC, emphasizing the cell-type specific characteristics of glucocorticoid action. We propose that specific inhibition of NF-kappaB activation in TEC might be an attractive strategy for therapeutic intervention in renal inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086895     DOI: 10.1111/j.1523-1755.2004.00553.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Cellular apoptosis in the cardiorenal axis.

Authors:  Grazia Maria Virzì; Anna Clementi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

2.  TWEAK activates the non-canonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21.

Authors:  Ana B Sanz; Maria D Sanchez-Niño; Maria C Izquierdo; Aniela Jakubowski; Pilar Justo; Luis M Blanco-Colio; Marta Ruiz-Ortega; Rafael Selgas; Jesús Egido; Alberto Ortiz
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

3.  The cytokine TWEAK modulates renal tubulointerstitial inflammation.

Authors:  Ana Belen Sanz; Pilar Justo; Maria Dolores Sanchez-Niño; Luis Miguel Blanco-Colio; Jeffrey A Winkles; Matthias Kreztler; Aniela Jakubowski; Julia Blanco; Jesús Egido; Marta Ruiz-Ortega; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

4.  Characterization and phosphoproteomic analysis of a human immortalized podocyte model of Fabry disease generated using CRISPR/Cas9 technology.

Authors:  Ester M Pereira; Anatália Labilloy; Megan L Eshbach; Ankita Roy; Arohan R Subramanya; Semiramis Monte; Guillaume Labilloy; Ora A Weisz
Journal:  Am J Physiol Renal Physiol       Date:  2016-09-28

5.  Dexamethasone ameliorates renal ischemia-reperfusion injury.

Authors:  Sanjeev Kumar; David A Allen; Julius E Kieswich; Nimesh S A Patel; Steven Harwood; Emanuela Mazzon; Salvatore Cuzzocrea; Martin J Raftery; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-09-24       Impact factor: 10.121

6.  Nephrin deficiency activates NF-kappaB and promotes glomerular injury.

Authors:  Sagair Hussain; Leile Romio; Moin Saleem; Peter Mathieson; Manuel Serrano; Jorge Moscat; Maria Diaz-Meco; Peter Scambler; Ania Koziell
Journal:  J Am Soc Nephrol       Date:  2009-06-04       Impact factor: 14.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.